Pruis MA, Krebs MG, Plummer R, De Vos F, et al. A Phase I Trial of the Dual MET Kinase/OCT-2 Inhibitor OMO-1 in Metastatic Solid Malignancies Including MET Exon 14 Mutated Lung Cancer. Oncologist 2023 Jun 1:oyad146. doi: 10.1093.
PMID: 37260332